TR␣1 and TR␤ mediate the regulatory effects of T 3 and have profound effects on the cardiovascular system. We have analyzed the expression of the cardiac myosin heavy chain (MyHC) genes ␣ and ␤ in mouse strains deficient for one or several TR genes to identify specific regulatory functions of TR␣1 and TR␤. The results show that TR␣1 deficiency, which slows the heart rate, causes chronic overexpression of MyHC␤. However, MyHC␤ was still suppressible by T 3 in both TR␣1-and TR␤-deficient mice, indicating that either receptor can mediate repression of MyHC␤. T 3 -dependent induction of the positively regulated MyHC␣ gene was similar in both TR␣1-and TR␤-deficient mice. The data identify a specific role for TR␣1 in the negative regulation of MyHC␤, whereas TR␣1 and TR␤ appear interchangeable for hormone-dependent induction of MyHC␣. This suggests that TR isoforms exhibit distinct specificities in the genes that they regulate within a given tissue type. Thus, dysregulation of MyHC␤ is likely to contribute to the critical role of TR␣1 in cardiac function. 
T HE ACTIVE FORM of thyroid hormone (TH), T 3 , plays a central role in the control of cardiac function by interacting with intracellular TRs. TRs are liganddependent transcription factors encoded by two different genes in mammals, each giving rise to several splice variants (1) (2) (3) (4) (5) . The best characterized isoforms are TR␣1, TR␣2, TR␤1, and TR␤2, of which all but TR␣2 bind T 3 in their C-terminal domains. Deletion studies in mice have shown that loss of TR␣1 slows heart rate and prolongs ventricular repolarization (6) , whereas the loss of TR␤ slightly elevates heart rate, probably through the higher levels of T 3 in these mice acting through TR␣1 (7, 8) . Deletion of both TR␣1 and TR␤ results in a similar phenotype as deletion of TR␣1 alone, thus indicating that TR␣1 has the primary role in regulating heart rate (Refs. 9-11a) .
The cardiac muscle myosin heavy chain (MyHC) ␣ and ␤ genes mediate contractility and are critical for normal heart function (12) (13) (14) . The MyHC genes are known to be regulated by T 3 , suggesting that their regulation underlies some of the major actions of T 3 in heart. The MyHC ␣ and ␤ proteins form homo-or heterodimers: MyHC␣ homodimers form the highATPase, V1 isoform; MyHC␤ homodimers form the low-ATPase, V3 isoform; and MyHC␣/␤ heterodimers form the V2 isoform (for review see Ref.
15). Each of these native myosin isoforms contains the same complement of myosin light chain. The compositions of myosin reflect the mechanical performance of the heart. In adult rat with fast contracting ventricles, MyHC␣ (V1) dominates (80-90%), whereas, during embryonic and fetal development, MyHC␤ is the predominant isoform. The shift in expression of MyHC at birth is coincident with a perinatal increase in circulating TH levels, indicating that TH is an important mediator of this transition. Thyroid response elements (TREs) have been located in both MyHC␣ and MyHC␤ genes, with MyHC␣ being positively regulated and MyHC␤ negatively regulated (4, 16, 17) .
TRs interact with specific TREs in target genes and thereby activate or repress transcription (18, 19) . On a positive TRE, TR can activate gene expression in the presence of T 3 and repress basal gene transcription in the absence of T 3 , thus indicating that TRs can also regulate transcription in a ligand-independent way. However, expression of certain target genes is downregulated by the ligand-bound receptor via a negative TRE (19, 20) .
Here we investigated the specific roles of the individual TR isoforms in regulation of the cardiac MyHC ␣ and ␤ genes, using TR␣1-and TR␤-deficient strains. Our results show that the MyHC genes are regulated by TRs in an isoform-and target gene-specific manner and identify molecular defects that underlie the cardiac phenotype in TR␣1-deficient mice.
RESULTS

Differential Expression of Cardiac MyHC␤ RNA in TR-Deficient Mice
Since TH is known to regulate the expression of MyHC␣ positively and MyHC␤ negatively, we determined the ratio of MyHC␣ to MyHC␤ expression in different TR-deficient mouse strains. We prepared polyAϩ RNA from the hearts of 4-to 6-month-old mice from three different TR-deficient strains and their corresponding wild-type (wt) animals. TR␣1Ϫ/Ϫ mice produce all TR isoforms except TR␣1, TR␤Ϫ/Ϫ mice express none of the TR␤ isoforms, whereas TR␣1Ϫ/Ϫ␤Ϫ/Ϫ animals express only TR␣2 (Refs. 6, 11a, 21, and 22).
The Northern blot analyses ( Fig. 1) showed that the expression of MyHC␤ was elevated 10-to 20-fold in TR␣1Ϫ/Ϫ and 50-fold in TR␣1Ϫ/Ϫ␤Ϫ/Ϫ mice, when comparing the different TR-deficient strains with their corresponding wt mice. This 50-fold induction of MyHC␤ in TR␣1Ϫ/Ϫ␤Ϫ/Ϫ mice was observed in repeated experiments ( Fig. 1 and data not shown) . A slight elevation of MyHC␤ was also seen in TR␤Ϫ/Ϫ mice. In contrast, no major difference in MyHC␣ expression was detectable in the different mouse strains. The results suggest that the different TR isoforms have distinct functions in regulation of the MyHC␤ gene and indicate that TR␣1 has the primary role in regulation of basal expression of the MyHC␤ gene. The exacerbated elevation of MyHC␤ in TR␣1Ϫ/Ϫ␤Ϫ/Ϫ mice, however, reveals the same phenotype in the absence of all known TRs and indicates a minor contributory role for TR␤ isoforms.
Hormonal Regulation of Cardiac MyHC RNA Expression by TR␣1؊/؊ and TR␤؊/؊ Mice
To assess the individual capacities of TR␣1 and TR␤ to regulate MyHC expression in vivo, the response of hypothyroid TR␣1Ϫ/Ϫ and TR␤Ϫ/Ϫ mice to increasing doses of injected T 3 was first determined. Animals (six mice per group) were first made hypothyroid by dietary treatment [iodine-deficient diet plus methimazole (LID ϩ MMI)], after which the mice were injected for 5 d with either a low dose of T 3 (0.05 g T 3 /d; LID ϩ MMI ϩ lT 3 ) or a higher dose (0.2 g T 3 /d; LID ϩ MMI ϩ hT 3 ). Table 1 shows the resultant serum levels of free T 3 (FT 3 ) and T 4 (FT 4 ). The higher dose of injected T 3 , raised the level of FT 3 to 19-24 pM in the TR␤Ϫ/Ϫ and corresponding wt strains. It is suggested that these mice yielded higher levels of FT 3 as compared with the TR␣1 strain due to their different genetic backgrounds, which also results in distinct levels of 5Ј-deiodinase in peripheral organs (23).
PolyAϩ RNA was prepared from hearts collected before treatment, after LID ϩ MMI diet, and after T 3 injections. Figure 2 , A and B, shows that although untreated TR␣1Ϫ/Ϫ mice expressed 13-fold higher levels of MyHC␤ RNA than the control animals, hypothyroidism resulted in similar, elevated levels in both animal groups. Injection of the low dose of T 3 resulted in a 20-fold reduction in the wt animals, whereas only a 6-fold reduction was seen in TR␣1Ϫ/Ϫ mice. The high dose of T 3 reduced the levels in both animal groups to below that seen in untreated wt mice. This shows that the TR␤ isoforms, at normal or low hormone levels, are insufficient for normal suppression of the MyHC␤ gene, whereas higher hormone levels enable TR␤ to suppress fully.
In both TR␤Ϫ/Ϫ and wt mice the induction of hypothyroidism caused an increase in MyHC␤ RNA (Fig.  3A) . However, the increase was only 16-fold in the TR␤-deficient mice as compared with 170-fold in wt controls. This reflects the higher TH levels observed in TR␤ Ϫ/Ϫ animals achieved after the LID ϩ MMI treatment and indicates that the treatment was not sufficient to achieve severe hypothyroidism in these mice. After T 3 injections the MyHC␤ gene was suppressed equally in both TR␤Ϫ/Ϫ and wt mice ( Table 1) . We conclude from these experiments that TR␣1 is needed to repress basal expression of MyHC␤ in the euthyroid state, and that both TR␣1 and TR␤ isoforms can repress the MyHC␤ gene after T 3 injections.
In contrast, there was no major difference in MyHC␣ expression levels, when comparing the TR␣1Ϫ/Ϫ and TR␤Ϫ/Ϫ mice with their respective wt controls (Figs. 2C and 3B). Upon TH deprivation, all groups of mice significantly reduced the MyHC␣ expression levels. Subsequent T 3 injections resulted in elevated MyHC␣ levels in all groups, as compared with their hypothyroid expression levels. Next, we subjected mice de- Figure 4 shows that MyHC␣ expression levels was unchanged in TR␣1Ϫ/Ϫ␤Ϫ/Ϫ mice during hypo-and hyperthy- 
Values are FT 3 and FT 4 serum concentration (picomoles/liter). The results from three animals in each group are expressed as mean Ϯ SEM. roidism. In this experiment a 2.5-fold higher T 3 dose was used, which could explain the higher induction of MyHC␣ seen in wt mice. We conclude that regulation of MyHC␣ requires nuclear TRs, but it is isoform independent (Figs. 2C, 3B, and 4, and Mansé n, A., unpublished data).
MyHC Protein Analysis
Next we determined whether the observed RNA levels reflected the amounts of protein. Mice from a separate animal experiment were used in this analysis. The protein analyses showed that the 10-to 20-fold elevation of MyHC␤ mRNA content in TR␣1Ϫ/Ϫ mice and the 50-fold increase in TR␣1Ϫ/Ϫ␤Ϫ/Ϫ mice caused a 16 Ϯ 3% and 25 Ϯ 4% increase (P Ͻ 0.001) in the relative content of the MyHC␤ protein isoform, respectively (Figs. 5, A and B, and 6). No MyHC␤ protein was detectable in untreated wt or TR␤Ϫ/Ϫ mice.
The relative amounts of MyHC␣ and MyHC␤ protein isoforms were not affected by changes in TH levels in the TR␣1-deficient mice, i.e. the relative amount of the MyHC␤ protein was 16 Ϯ 3%, 19 Ϯ 5%, and 27 Ϯ 3% in the untreated, LID ϩ MMI-treated, and LID ϩ MMI ϩ T 3 -treated animals (Fig. 5, A and B) . The wt mice, in contrast, showed an increase in the MyHC␤ protein isoform (35 Ϯ 11%) expression as a response to LID ϩ MMI treatment and a decrease in the MyHC␤ content (17 Ϯ 4%) after the T 3 injections.
The 2-to 3-fold elevation of MyHC␤ RNA seen in the TR␤Ϫ/Ϫ mice did not result in detectable MyHC protein (Fig. 5) . However, the MyHC␤ protein content increased in both TR␤Ϫ/Ϫ and wt mice in response to the LID ϩ MMI diet. The 16-fold increase in MyHC␤ mRNA content in TR␤Ϫ/Ϫ and the 170-fold increase in the wt mice were paralleled by a significant change at the protein level, i.e. the MyHC␤ protein content was 15 Ϯ 4% in TR␤Ϫ/Ϫ and 28 Ϯ 8% in wt animals after LID ϩ MMI treatment as compared with 0% in the untreated TR␤Ϫ/Ϫ and wt mice (Fig. 5, A and C) . T 3 injections did not induce any further change in MyHC isoform expression in either TR␤Ϫ/Ϫ or wt mice.
The MyHC␤ contents were similar in untreated (25 Ϯ 4%) and LID ϩ MMI-treated (19%, n ϭ 1) TR␣1Ϫ/Ϫ␤Ϫ/Ϫ mice, and the MyHC␤ protein contents observed in the LID ϩ MMI-treated (34 Ϯ 18%) wt mice did not differ from that in TR␣1/␤-deficient mice (Fig. 6) .
The relatively high MyHC␤ protein content, in spite of the low mRNA level in the animals after T 3 injections, is most probably related to the slow turnover rate of cardiac myosin protein [5-6 d half-life (24)] as compared with myosin mRNA [within hours (25)].
DISCUSSION
The TR isoforms ␣1 and ␤ regulate distinct functions, e.g. TR␣1 plays an important role in determining basal heart rate, whereas TR␤ is required for proper auditory functions and eye development, as well as for regulation of several liver enzymes (6, 21, 23, (26) (27) (28) (29) . Here, we have studied the specific regulation by TR isoforms of the MyHC ␣ and ␤ genes because they are differentially regulated by TH and are expressed in the same cells of the heart. The results show that the negatively regulated MyHC␤ gene can be regulated by both TR␣1 and TR␤. However, the receptors have distinct The bar diagrams show relative expression levels in wt and TR␤Ϫ/Ϫ mice of MyHC␤ (A) and MyHC␣ (B). Results were obtained from Northern blots hybridization containing 2 g RNA from wt and TR␤-deficient mice on normal diet (ND), diet inducing hypothyroidism (LID ϩ MMI), or injected with a low (LID ϩ MMI ϩ lT 3 ) or high dose (LID ϩ MMI ϩ hT 3 ) of T 3 . Levels of RNA expression were normalized to that of G3PDH, and results are expressed as mean correlated to the expression in wt euthyroid mice, which was set to 1.0. Each bar represents mean Ϯ SEM from three animals.
roles. MyHC␤ expression was elevated both at the mRNA and protein levels in untreated TR␣1Ϫ/Ϫ and TR␣1Ϫ/Ϫ␤Ϫ/Ϫ, but not in TR␤Ϫ/Ϫ mice, suggesting that TR␣1 is required for suppression of basal levels of MyHC␤ expression. This is further supported by Gloss et al. (10) , who recently noted that TR␤Ϫ/Ϫ mice that had been rendered euthyroid experimentally expressed levels of MyHC␤ similar to those of wt controls.
The TR␣1Ϫ/Ϫ␤Ϫ/Ϫ mice, lacking all known T 3 -binding receptors, had a 50-fold increase in MyHC␤ mRNA ( Fig. 1 and data not shown) . This increase is similar to that seen in the hypothyroid TR␣1Ϫ/Ϫ and wt animals. These conclusions are reminiscent of previous observations with the negatively regulated TSH␤ gene: mice lacking both TR␣1 and TR␤ (TR␣1Ϫ/Ϫ␤Ϫ/Ϫ) have serum TSH and TSH␤ mRNA levels (Ref. 21, and Mansé n, A., unpublished data) that are similar to those found in severely hypothyroid mice. Thus, a mechanism of MyHC␤ gene activation by an aporeceptor may not be required.
TR␣1 and TR␤ also exhibit differences in their ability to suppress MyHC␤ expression after injection of T 3 . A low dose of T 3 allowed wt mice to down-regulate MyHC␤ RNA 20-fold, whereas only a 6-fold reduction was seen in the TR␣1Ϫ/Ϫ mice. This suggests that TR␤ is less efficient than TR␣1 or, alternatively, that the two receptors act in concert in suppressing MyHC␤ at low serum levels of T 3 . However, our data also show that TR␤ can, at higher serum T 3 levels, efficiently suppress MyHC␤. Taken together, our results indicate that TR␣1 is more efficient than TR␤ in suppressing MyHC␤. TR␣2 appears to have, at most, a minor effect on MyHC␤ expression.
The MyHC␣ gene is, in contrast to MyHC␤, induced by T 3 . No significant differences in MyHC␣ expression were observed in three independent experiments between untreated wt and the respective TR-deficient mice. Furthermore, the regimen used for inducing a hypothyroid state in the mice achieved a similar repression of MyHC␣ RNA levels in the TR␣1Ϫ/Ϫ, TR␤Ϫ/Ϫ, and control strains. Thus, we cannot ascribe a specific TR isoform a role in regulating the MyHC␣ gene. It is also noteworthy that the 5-d T 3 injection regimen did not significantly increase the MyHC␣ levels above those seen in untreated mice, irrespective of the mouse strain studied. We have therefore examined the induction levels of MyHC␣ 2 h after injection of T 3 . This treatment did not result in an induction of MyHC␣ above that seen in untreated mice (data not shown). Therefore, the data indicate that in vivo, the major role of TRs in regulation of the MyHC␣ gene is to suppress expression during hypothyroidism and to relieve repression when ligand becomes available.
Gloss et al. (10) reported that TR␣1 is expressed 3-fold higher than TR␤ on the RNA level in the mouse heart. It is therefore possible that the efficient suppression of MyHC␤ by TR␣1 is due to its higher expression level. A further increase in TR␣1 expression, as seen in the TR␣2 mice (11a), results in increased efficiency in hormone-dependent down-regulation of MyHC␤ (Mansé n, A., unpublished data), thus supporting the hypothesis that receptor levels are important for gene regulation in vivo. However, we cannot exclude that possible differences between the receptors in binding to promoter-specific TREs or to corepressors also contribute to the relative efficacy of T 3 -dependent TR␣1-mediated gene suppression. Nevertheless, MyHC␣ and MyHC␤ are expressed in the same cell type, indicating that TR␣1 and TR␤ have distinct intrinsic gene-regulatory properties in vivo.
Adult mice have a high heart rate and accordingly express little or no MyHC␤ (15) . Recently, Tardiff et al. (30) developed transgenic mice that significantly overexpress MyHC␤ (ϩ12%) in the heart. These mice exhibit a decreased cardiac contractility, indicating that a Table 1. shift in cardiac myosin composition, such as those we have described, markedly affects cardiac function. This is further supported by studies on transgenic mice expressing a dominant negative TR␤ (31, 32). Both mouse strains expressed highly elevated levels of MyHC␤ RNA, possibly as a consequence of an inability of the mutant TR␤ to down-regulate the MyHC␤ gene. Furthermore, a TR␣-deficient mouse strain different from the one used by us showed a decreased MyHC␣ expression, which may be correlated to a shift in total myosin composition (10) . The mouse strains referred to above have diminished contractile function, which was attributed to decreased MyHC␣ and sarcoplasmic reticulum Ca 2ϩ ATPase levels (10, 31, 32) . Since the mice analyzed by us carried genetically altered TRs similar to those studied by Gloss et al. (10) , it is highly likely that the TR␣1-deficient mice we have studied have similar deficiencies in contractile function.
MATERIALS AND METHODS
Hormone Determinations
Free T 3 and T 4 were measured using the Amerlex-MAB kit (Piscataway, NJ) as described previously (6) .
Northern Blot Analyses
Polyadenylated RNA was prepared from frozen heart (ventricle and atrium) (33). Each preparation corresponds to one or two hearts as indicated in the figure legends and 2-5 g mRNA were loaded per lane. Northern blots were hybridized with oligonucleotide probes specific for MyHC␣ or MyHC␤ (34). Hybridization with glyceraldehyde-3-phosphate dehydrogenase (G3PDH) probe (CLONTECH Laboratories, Inc., Palo Alto, CA) served as a control for equivalent loading of mRNA. Levels of MyHC␣ and MyHC␤ mRNA expression were normalized to that of G3PDH mRNA using a PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) and BAS-2500 film (Fuji Photo Film Co., Ltd., Stamford, CT) for quantification. Data are presented as means Ϯ SEM.
Animals and Experimental Setup
The Institutional Animal Care and Use Committee approved the studies. Genotyping was done by PCR or Southern blot analysis (6, 22) . The genetic backgrounds of the mice differ among the different mouse strains (6, 21, 22) . However, all wt control and TR-deficient mice used in this study were obtained from crosses between heterozygotes for the respective knockout strain. The control strains were bred in parallel form with the receptor-deficient strains for three to four generations, at which point new heterozygotes produced inbreeding, followed by renewed heterozygote breeding for homozygote wt and knockout strains. The control strains therefore had the same, mixed genetic background as their respective receptor-deficient strain. In summary, TR␤ mice hybrid of 129/Sv ϫ C57Bl/6J, TR␣1 mice hybrid of 129/ OlaHsd ϫ BALB/c, and the TR␣1/␤ mice were obtained from crosses of the above lines. The allele nomenclature suggested by the Mouse Nomenclature Guidelines & Locus Symbol Registry at The Jackson Laboratory (Bar Harbor, ME) is simplified in the text for readability. Thus Thra tm1Ven/tm1Ven is denoted TR␣1Ϫ/Ϫ, Thrb tm1Df/tm1Df is denoted TR␤Ϫ/Ϫ, and finally Thra tm1Ven/tm1Ven Thrb tm1Df/tm1Df is denoted TR␣1Ϫ/Ϫ␤Ϫ/Ϫ.
Hypothyroidism was induced by an initial treatment of 2-to 5-month-old male mice with LID (R584, AnalyCen, Nordic AB, Lidkö ping, Sweden) for 14 d, followed by addition of 0.05% MMI and 1% potassium perchlorate to the drinking water) for an additional 21 d (LID ϩ MMI). Thereafter, the mice were injected daily with either a low dose T 3 (0.05 g T 3 /d; LID ϩ MMI ϩ lT 3 ) or a higher dose T 3 (0.2 g T 3 /d; LID ϩ MMIϩ hT 3 ) for an additional 5 d to induce hyperthyroidism (Table 1 ) (27). The low dose of T 3 was designed to raise the serum levels in hypothyroid mice to below normal. The treatment with LID ϩ MMI significantly lowered the FT 3 /FT 4 levels as compared with untreated mice. Since all animals given T 3 injections were first made hypothyroid, we achieved maximal response to the T 3 injections. The experimental setup for the TR␣1Ϫ/ Ϫ␤Ϫ/Ϫ and their wt controls was essentially as above; however, the LID treatment was extended to 21 d, followed by a period of 5 weeks on LID ϩ MMI treatment, and finally 5 d of T 3 injections (0.5 g T 3 /d). Serum and organs were collected 1 d after the last T 3 injection. A total of 24 mice of each TR␣1Ϫ/Ϫ and TR␤Ϫ/Ϫ plus an additional 24 of the respective wt animals was used in the experiments. The number of TR␣1Ϫ/Ϫ␤Ϫ/Ϫ and wt mice used was 18 of each genotype. Six animals from each group were killed for analysis at each change of diet, although serum samples for hormone deter- minations were obtained from all mice. Animals that responded well to the dietary treatments, as judged by their FT 3 and FT 4 levels (Table 1) , were selected for further Northern analyses.
The experiments in Fig. 1 have been repeated three times; those in Figs. 2 and 3 were repeated four times, respectively, and that in Fig. 4 was repeated once. The samples shown in Fig. 1 represent a pool of RNA from two animals (females, 4 to 6 months old) of each genotype (12 mice total).
Electrophoretic Separation of Cardiac MyHC Isoform Composition
Frozen hearts (left and right ventricles) from a total of 88 mice of different TR strains were sectioned 10 m thick with a cryotome (2800 Frigocut-E, Reichert-Jung GmbH, Heidelberg, Germany) at Ϫ20 C. Appropriate amounts of sample buffer (333 l sample buffer/1 mg of wet tissue) were added according to the areas of each cross-section (3 ϫ 10 5 m 2 /1 l sample buffer). The loading volumes of each sample were kept at 4 l.
The MyHC composition was determined by SDS-PAGE (35). The total bis-acrylamide concentrations were 4% (wt/ vol) in the stacking gel and 7% in the running gel (0.75 mm thick), with acrylamide: N,NЈ-methylene-bis-acrylamide in the ratio of 50:1. The gel matrix (both stacking and separating gels) included 5% glycerol as described previously (36). The gels were placed in the electrophoresis apparatus (SE 600 vertical slab gel unit, Hoefer Scientific, San Francisco, CA) connected to a power supply and a cooling unit. Electrophoresis was performed at 215 V for 22 h with a Tris-glycine electrode buffer (pH 8.3) at 10 C. Separating gels were silver stained and subsequently scanned in a soft laser densitometer (Molecular Dynamics, Inc.) with a high spatial resolution (50-m pixel spacing) and 4,096 OD levels to determine the relative contents of the MyHC isoforms. The volume integration function was used to quantify the relative amount of protein (37), and background activity was subtracted from all pixel values (ImageQuant Software version 3.3, Molecular Dynamics, Inc.).
Means and SEM values were calculated from individual values by standard procedures. A two-way ANOVA was applied to test for the effect of TR deficiency and TH levels within each mouse strain. Differences were considered significant at P Ͻ 0.05. 
